Abstract
Disease recurrence is the most common cause of death for patients with breast cancer, yet little is known about the molecular mechanisms underlying this process. Using inducible transgenic mouse model systems, Feng and colleagues identified SPSB1 as a determinant of breast cancer recurrence by virtue of its ability to protect tumor cells from apoptosis through c-MET activation. © 2014 American Association for Cancer Research.
Cite
CITATION STYLE
APA
Qin, Y., & McAllister, S. S. (2014). SPSB1 may have MET its match during breast cancer recurrence. Cancer Discovery, 4(7), 760–761. https://doi.org/10.1158/2159-8290.CD-14-0505
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free